IVVD Strangle Strategy
IVVD (Invivyd, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
IVVD (Invivyd, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $195.1M, a beta of 0.71 versus the broader market, a 52-week range of 0.483-3.07, average daily share volume of 2.6M, a public-listing history dating back to 2021, approximately 99 full-time employees. These structural characteristics shape how IVVD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.71 places IVVD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on IVVD?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current IVVD snapshot
As of May 15, 2026, spot at $1.21, ATM IV 91.20%, IV rank 14.63%, expected move 26.15%. The strangle on IVVD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on IVVD specifically: IVVD IV at 91.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a IVVD strangle, with a market-implied 1-standard-deviation move of approximately 26.15% (roughly $0.32 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IVVD expiries trade a higher absolute premium for lower per-day decay. Position sizing on IVVD should anchor to the underlying notional of $1.21 per share and to the trader's directional view on IVVD stock.
IVVD strangle setup
The IVVD strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IVVD near $1.21, the first option leg uses a $1.27 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IVVD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IVVD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.27 | N/A |
| Buy 1 | Put | $1.15 | N/A |
IVVD strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
IVVD strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on IVVD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on IVVD
Strangles on IVVD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVVD chain.
IVVD thesis for this strangle
The market-implied 1-standard-deviation range for IVVD extends from approximately $0.89 on the downside to $1.53 on the upside. A IVVD long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current IVVD IV rank near 14.63% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IVVD at 91.20%. As a Healthcare name, IVVD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IVVD-specific events.
IVVD strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IVVD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IVVD alongside the broader basket even when IVVD-specific fundamentals are unchanged. Always rebuild the position from current IVVD chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on IVVD?
- A strangle on IVVD is the strangle strategy applied to IVVD (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With IVVD stock trading near $1.21, the strikes shown on this page are snapped to the nearest listed IVVD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IVVD strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the IVVD strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 91.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IVVD strangle?
- The breakeven for the IVVD strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IVVD market-implied 1-standard-deviation expected move is approximately 26.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on IVVD?
- Strangles on IVVD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVVD chain.
- How does current IVVD implied volatility affect this strangle?
- IVVD ATM IV is at 91.20% with IV rank near 14.63%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.